Bayer AG (OTC Pink - Current Information:BAYRY)
| 8.45 Delayed Data As of Dec 01 |  -0.07 / -0.82%Today’s Change | 8.31 Today|||52-Week Range 17.00 | -34.29% Year-to-Date |
Latest BAYRY News | Press Releases
| Bristol Myers (BMY), TSVT Cell Therapy Abecma Faces Setback Nov 21 / Zacks.com - Paid Partner Content | Bayer (BAYRY) Stops Heart Drug Study Due to Lack of Efficacy Nov 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 8.52 |
| Today’s open | 8.36 |
| Day’s range | 8.33 - 8.45 |
| Volume | 1,336,991 |
| Average volume (3 months) | 1,200,786 |
| Market cap | $33.2B |
Data as of 12/01/2023
Growth & Valuation
| Earnings growth (last year) | +268.98% |
| Earnings growth (this year) | -10.42% |
| Earnings growth (next 5 years) | +0.40% |
| Revenue growth (last year) | +2.35% |
| P/E ratio | -- |
| Price/Sales | 0.95 |
| Price/Book | 0.80 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 5, 2024 |
| EPS forecast (this quarter) | $0.39 |
| Annual revenue (last year) | $53.3B |
| Annual profit (last year) | $4.4B |
| Net profit margin | 8.18% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Leverkusen, Nordrhein-westfalen |
Forecasts
Chart unavailable
